Peptidoglycan fragment release from neisseria meningitidis

Infection and Immunity

Volumn 81, Issue 9, 2013, Pages 3490-3498

  Woodhams, Katelynn L ^a   Chan, Jia Mun ^a   Lenz, Jonathan D ^a   Hackett, Kathleen T ^a   Dillard, Joseph P ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 4; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; MONOMER; PEPTIDE FRAGMENT; PEPTIDOGLYCAN; PERMEASE;

ALLELE; ARTICLE; CELL DEATH; CILIATED EPITHELIUM; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVITY; INFLAMMATION; NEISSERIA GONORRHOEAE; NEISSERIA MENINGITIDIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PROCESSING; PROTEIN SECRETION; SUPERNATANT; UTERINE TUBE;

EID: 84884256449     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00279-13     Document Type: Article

References (44)

1. Stephens DS, Greenwood B, Brandtzaeg P. 2007. Epidemic meningitis, meningococcaemia, and Neisseria meningitidis. Lancet 369:2196-2210.
2. Cohn AC, MacNeil JR, Harrison LH, Hatcher C, Theodore J, Schmidt M, Pondo T, Arnold KE, Baumbach J, Bennett N, Craig AS, Farley M, Gershman K, Petit S, Lynfield R, Reingold A, Schaffner W, Shutt KA, Zell ER, Mayer LW, Clark T, Stephens D, Messonnier NE. 2010. Changes in Neisseria meningitidis disease epidemiology in the United States, 1998-2007: implications for prevention of meningococcal disease. Clin. Infect. Dis. 50:184-191.
3. Girardin SE, Boneca IG, Carneiro LA, Antignac A, Jehanno M, Viala J, Tedin K, Taha MK, Labigne A, Zahringer U, Coyle AJ, DiStefano PS, Bertin J, Sansonetti PJ, Philpott DJ. 2003. Nod1 detects a unique muropeptide from gram-negative bacterial peptidoglycan. Science 300:1584-1587.
4. Rosenthal RS. 1979. Release of soluble peptidoglycan from growing gonococci: hexaminidase and amidase activities. Infect. Immun. 24:869-878.
5. Hebeler BH, Young FE. 1976. Chemical composition and turnover of peptidoglycan in Neisseria gonorrhoeae. J. Bacteriol. 126:1180-1185.
6. Garcia DL, Dillard JP. 2008. Mutations in ampG or ampD affect peptidoglycan fragment release from Neisseria gonorrhoeae. J. Bacteriol. 190:3799-3807.
7. Jacobs C, Huang LJ, Bartowsky E, Normark S, Park JT. 1994. Bacterial cell wall recycling provides cytosolic muropeptides as effectors for betalactamase induction. EMBO J. 13:4684-4694.
8. Lindquist S, Weston-Hafer K, Schmidt H, Pul C, Korfmann G, Erickson J, Sanders C, Martin HH, Normark S. 1993. AmpG, a signal transducer in chromosomal beta-lactamase induction. Mol. Microbiol. 9:703-715.
9. Johnson JW, Fisher JF, Mobashery S. 2013. Bacterial cell-wall recycling. Ann. N. Y. Acad. Sci. 1277:54-75.
10. Goldman WE, Klapper DG, Baseman JB. 1982. Detection, isolation, and analysis of a released Bordetella pertussis product toxic to cultured tracheal cells. Infect. Immun. 36:782-794.
11. Rosenthal RS, Nogami W, Cookson BT, Goldman WE, Folkening WJ. 1987. Major fragment of soluble peptidoglycan released from growing Bordetella pertussis is tracheal cytotoxin. Infect. Immun. 55:2117-2120.
12. Heiss LN, Moser SA, Unanue ER, Goldman WE. 1993. Interleukin-1 is linked to the respiratory epithelial cytopathology of pertussis. Infect. Immun. 61:3123-3128.
13. Flak TA, Goldman WE. 1999. Signalling and cellular specificity of airway nitric oxide production in pertussis. Cell. Microbiol. 1:51-60.
14. McGee ZA, Johnson AP, Taylor-Robinson D. 1981. Pathogenic mechanisms of Neisseria gonorrhoeae: observations on damage to human fallopian tubes in organ culture by gonococci of colony type 1 or type 4. J. Infect. Dis. 143:413-422.
15. Melly MA, McGee ZA, Rosenthal RS. 1984. Ability of monomeric peptidoglycan fragments from Neisseria gonorrhoeae to damage human fallopian-tube mucosa. J. Infect. Dis. 149:378-386.
16. Nigro G, Fazio LL, Martino MC, Rossi G, Tattoli I, Liparoti V, De Castro C, Molinaro A, Philpott DJ, Bernardini ML. 2008. Muramylpeptide shedding modulates cell sensing of Shigella flexneri. Cell. Microbiol. 10:682-695.
17. Girardin SE, Jehanno M, Mengin-Lecreulx D, Sansonetti PJ, Alzari PM, Philpott DJ. 2005. Identification of the critical residues involved in peptidoglycan detection by Nod1. J. Biol. Chem. 280:38648-38656.
18. Kellogg DS, Jr, Peacock WL, Jr, Deacon WE, Brown L, Pirkle CL. 1963. Neisseria gonorrhoeae. I. Virulence genetically linked to clonal variation. J. Bacteriol. 85:1274-1279.
19. Rosenthal RS, Dziarski R. 1994. Isolation of peptidoglycan and soluble peptidoglycan fragments. Methods Enzymol. 235:235-285.
20. Cloud KA, Dillard JP. 2002. A lytic transglycosylase of Neisseria gonorrhoeae is involved in peptidoglycan-derived cytotoxin production. Infect. Immun. 70:2752-2757.
21. Kohler PL, Hamilton HL, Cloud-Hansen K, Dillard JP. 2007. AtlA functions as a peptidoglycan lytic transglycosylase in the Neisseria gonorrhoeae type IV secretion system. J. Bacteriol. 189:5421-5428.
22. Cloud-Hansen KA, Hackett KT, Garcia DL, Dillard JP. 2008. Neisseria gonorrhoeae uses two lytic transglycosylases to produce cytotoxic peptidoglycan monomers. J. Bacteriol. 190:5989-5994.
23. Sinha RK, Rosenthal RS. 1980. Release of soluble peptidoglycan from growing gonococci: demonstration of anhydro-muramyl-containing fragments. Infect. Immun. 29:914-925.
24. Lee M, Hesek D, Llarrull LI, Lastochkin E, Pi H, Boggess B, Mobashery S. 2013. Reactions of all Escherichia coli lytic transglycosylases with bacterial cell wall. J. Am. Chem. Soc. 135:3311-3314.
25. Heidrich C, Templin MF, Ursinus A, Merdanovic M, Berger J, Schwarz H, de Pedro MA, Höltje JV. 2001. Involvement of N-acetylmuramyl-Lalanine amidases in cell separation and antibiotic-induced autolysis of Escherichia coli. Mol. Microbiol. 41:167-178.
26. Girardin SE, Tournebize R, Mavris M, Page AL, Li X, Stark GR, Bertin J, DiStefano PS, Yaniv M, Sansonetti PJ, Philpott DJ. 2001. CARD4/Nod1 mediates NF-kappaB and JNK activation by invasive Shigella flexneri. EMBO Rep. 2:736-742.
27. Melly MA, Gregg CR, McGee ZA. 1981. Studies of toxicity of Neisseria gonorrhoeae for human fallopian tube mucosa. J. Infect. Dis. 143:423-431.
28. Maisey K, Nardocci G, Imarai M, Cardenas H, Rios M, Croxatto HB, Heckels JE, Christodoulides M, Velasquez LA. 2003. Expression of proinflammatory cytokines and receptors by human fallopian tubes in organ culture following challenge with Neisseria gonorrhoeae. Infect. Immun. 71:527-532.
29. McGee ZA, Clemens CM, Jensen RL, Klein JJ, Barley LR, Gorby GL. 1992. Local induction of tumor necrosis factor as a molecular mechanism of mucosal damage by gonococci. Microb. Pathog. 12:333-341.
30. Velasquez L, Garcia K, Morales F, Heckels JE, Orihuela P, Rodas PI, Christodoulides M, Cardenas H. 2012. Neisseria gonorrhoeae pilus attenuates cytokine response of human fallopian tube explants. J. Biomed. Biotechnol. 2012:491298.
31. Typas A, Banzhaf M, Gross CA, Vollmer W. 2012. From the regulation of peptidoglycan synthesis to bacterial growth and morphology. Nat. Rev. Microbiol. 10:123-136.
32. Boudreau MA, Fisher JF, Mobashery S. 2012. Messenger functions of the bacterial cell wall-derived muropeptides. Biochemistry 51:2974-2990.
33. Koropatnick TA, Engle JT, Apicella MA, Stabb EV, Goldman WE, McFall-Ngai MJ. 2004. Microbial factor-mediated development in a hostbacterial mutualism. Science 306:1186-1188.
34. Zughaier SM, Tzeng YL, Zimmer SM, Datta A, Carlson RW, Stephens DS. 2004. Neisseria meningitidis lipooligosaccharide structure-dependent activation of the macrophage CD14/Toll-like receptor 4 pathway. Infect. Immun. 72:371-380.
35. Massari P, Visintin A, Gunawardana J, Halmen KA, King CA, Golenbock DT, Wetzler LM. 2006. Meningococcal porin PorB binds to TLR2 and requires TLR1 for signaling. J. Immunol. 176:2373-2380.
36. Greenway DL, Perkins HR. 1985. Turnover of the cell wall peptidoglycan during growth of Neisseria gonorrhoeae and Escherichia coli. Relative stability of newly synthesized material. J. Gen. Microbiol. 131:253-263.
37. Uehara T, Park JT. 2007. An anhydro-N-acetylmuramyl-L-alanine amidase with broad specificity tethered to the outer membrane of Escherichia coli. J. Bacteriol. 189:5634-5641.
38. Magalhaes JG, Philpott DJ, Nahori MA, Jehanno M, Fritz J, Le Bourhis L, Viala J, Hugot JP, Giovannini M, Bertin J, Lepoivre M, Mengin-Lecreulx D, Sansonetti PJ, Girardin SE. 2005. Murine Nod1 but not its human orthologue mediates innate immune detection of tracheal cytotoxin. EMBO Rep. 6:1201-1207.
39. Luker K, Tyler A, Marshall G, Goldman W. 1995. Tracheal cytotoxin structural requirements for respiratory epithelial damage in pertussis. Mol. Microbiol. 16:733-743.
40. Woodhams KL, Benet ZL, Blonsky SE, Hackett KT, Dillard JP. 2012. Prevalence and detailed mapping of the gonococcal genetic island in Neisseria meningitidis. J. Bacteriol. 194:2275-2285.
41. Swanson J. 1972. Studies on gonococcus infection. II. Freeze-fracture, freeze-etch studies on gonococci. J. Exp. Med. 136:1258-1271.
42. Hamilton HL, Schwartz KJ, Dillard JP. 2001. Insertion-duplication mutagenesis of Neisseria: use in characterization of DNA transfer genes in the gonococcal genetic island. J. Bacteriol. 183:4718-4726.
43. Ram S, Cox AD, Wright JC, Vogel U, GetzlaffS, Boden R, Li J, Plested JS, Meri S, Gulati S, Stein DC, Richards JC, Moxon ER, Rice PA. 2003. Neisserial lipooligosaccharide is a target for complement component C4b. Inner core phosphoethanolamine residues define C4b linkage specificity. J. Biol. Chem. 278:50853-50862.
44. Ramsey ME, Hackett KT, Kotha C, Dillard JP. 2012. New complementation constructs for inducible and constitutive gene expression in Neisseria gonorrhoeae and Neisseria meningitidis. Appl. Environ. Microbiol. 78:3068-3078.